EGFR and glioblastoma: Because patients with IDH1-mutated primary glioblastoma are generally younger and have longer median survival and wild-type EGFR, which are characteristics of secondary glioblastoma, it is hypothesized that these are in fact secondary glioblastomas for which no histological evidence of evolution from a less malignant glioma is found.